The patient seemed to demonstrate typical noncompliance behaviors. Until one day her appearance suggested another explanation, prompting an investigation that revealed a surprising cause.
How long were you a nurse before you felt competent? Reflections on creating an atmosphere of learning and growing from our own mistakes.
At what point is attentiveness being too nice? Ann Brady discusses how her words followed the patient's wishes, but her actions prompted an unexpected question.
Reflecting on the 2 meanings of this simple word helps explain the nuances of communicating with cancer patients and their families at pivotal points of care.
Are the difficult questions easier to answer when the patient still has treatment options available? Ann Brady talks about helping patients and families navigate the changes in disease and care.
Loss of appetite and not eating are difficult aspects of cancer for patients' loved ones to understand. Continued and diligent nurse education can help both patients and families cope with this disturbing effect.
Providing your patient with the opportunity to tell his or her story helps to ensure that the goals of treatment are defined and met.
Patients' constant proximity to nurses gives them opportunities and the ease of familiarity to ask difficult questions. When answering, nurses should remember that part of the answer is the patient's choice of who to ask.
Despite the experience of the oncology care team, it is important to remember to ask before acting when it comes to patient care.
Patients at a crossroads in their care may struggle with the decision to change the course of their care. Nurses need to find the balance between offering support and letting the patient go forward.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Best Approach to Infection and Tumor Treatment: Contain or Eliminate?
- Decipher Genomic Classifier Prognostic for Distant Prostate Metastasis
- GUCS 2017: Adjuvant Trials in Post-radical Prostatectomy Prostate Cancer Feasible
- Annual Screening of High-Risk Smokers Only More Cost-effective Than Current Methods
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|